News - ChemRar Hi-Tech

Filter

Current filters:

ChemRar Hi-Tech

Popular Filters

Agenus out-licenses Russian rights to cancer vaccine

20-12-2011

US biotech firm Agenus (Nasdaq: AGEN), known as Antigenics until January of this year, has entered into…

AgenusAntigenicsBiotechnologyChemRar Hi-TechEuropeLicensingNephrology and HepatologyNewVacOncologyOncophagePharmaceuticalResearch

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top